UNSPSC 85722666: Fusion of left metatarsal-tarsal joint with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to fusion of left metatarsal-tarsal joint with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SGL4KZ

UNSPSC 85722666, Fusion of left metatarsal-tarsal joint with nonautologous tissue substitute, percutaneous endoscopic approach, is a Commodity code that does not align with state and local government procurement activity reflected in recent solicitations. The code nominally describes a specific orthopedic surgical procedure, but the recent opportunities posted under this code are for occupational medical surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-out programs, and emergency medical services for detained youth — none of which involve the particular joint-fusion procedure the code names. This mismatch suggests either a systematic tagging error in the state and local procurement database or that the code has been misapplied to a family of broader health services work that does not correspond to the Commodity's specific clinical definition.

The recent opportunities do show activity across state departments, counties, and municipalities, including the Washington State Department of Transportation (WSF medical surveillance), Harris County Juvenile Probation Department (emergency medical services), Collier County (pharmacy benefit management), the City of Phoenix (disability medical evaluations), the City of Long Beach (surgical benefits carve-out), and Santa Clara County Health System (temporary health professional staffing). All six posted since July 2026, with response dates ranging from September through October 2026. Given the fundamental mismatch between the code's clinical scope and the health administration and staffing services actually being bought, this code shows little relevant recent activity for firms pursuing orthopedic implant or surgical-procedure contracts.